Combination of cryosurgery and topical imiquimod: does timing matter for successful immunocryosurgery?
Ioannis D
ID
Bassukas
Georgios
G
Gaitanis
D000287:Administration, Topical; D000634:Aminoquinolines / Q000008:administration & dosage*; D000951:Antigens, Neoplasm / Q000378:metabolism; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017209:Apoptosis; D003131:Combined Modality Therapy; D003452:Cryosurgery / Q000379:methods*; D003713:Dendritic Cells / Q000378:metabolism; D006801:Humans; D000077271:Imiquimod; D007165:Immunosuppression Therapy; D007167:Immunotherapy / Q000379:methods; D007911:Lentigo / Q000188:drug therapy* / Q000601:surgery*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D013997:Time Factors; D051193:Toll-Like Receptors / Q000378:metabolism*
D000634:Aminoquinolines; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D051193:Toll-Like Receptors; D000077271:Imiquimod